Author:
Logothetis Christopher,Morris Michael J.,Den Robert,Coleman Robert E.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. National Cancer Institute. (2017). SEER Cancer Stat Facts: prostate cancer.
http://seer.cancer.gov/statfacts/html/prost.html
. Accessed August 9, 2017.
2. Sweeney, C. J., Chen, Y.-H., Carducci, M., Liu, G., Jarrard, D. F., Eisenberger, M., et al. (2015). Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. New England Journal of Medicine, 373(8), 737–746.
https://doi.org/10.1056/NEJMoa1503747
.
3. Aparicio, A. M., Shen, L., Tapia, E. L. N., Lu, J.-F., Chen, H.-C., Zhang, J., et al. (2016). Combined tumor suppressor defects characterize clinically defined aggressive variant prostate cancers. Clinical Cancer Research, 22(6), 1520–1530.
https://doi.org/10.1158/1078-0432.ccr-15-1259
.
4. Tzelepi, V., Zhang, J., Lu, J.-F., Kleb, B., Wu, G., Wan, X., et al. (2012). Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clinical Cancer Research, 18(3), 666–677.
https://doi.org/10.1158/1078-0432.ccr-11-1867
.
5. Mu, P., Zhang, Z., Benelli, M., Karthaus, W. R., Hoover, E., Chen, C.-C., et al. (2017). SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science (New York, N.Y.), 355(6320), 84–88.
https://doi.org/10.1126/science.aah4307
.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献